Articles from Benzinga
Israel-Hamas Ceasefire Deal Nears As Mediators Push For Breakthrough In Doha Talksbenzinga.com
After weeks of diplomacy, a draft ceasefire has been handed to Israel and Hamas with provisions for hostage release. Talks continue for finalization.
Via Benzinga · January 13, 2025
Breaking Down ASML Holding: 5 Analysts Share Their Viewsbenzinga.com
Via Benzinga · January 13, 2025
Expert Outlook: Essex Property Trust Through The Eyes Of 4 Analystsbenzinga.com
Via Benzinga · January 13, 2025
What 5 Analyst Ratings Have To Say About Allegro Microsystemsbenzinga.com
Via Benzinga · January 13, 2025
Forecasting The Future: 10 Analyst Projections For Flowservebenzinga.com
Via Benzinga · January 13, 2025
$1000 Invested In Workday 10 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · January 13, 2025
IonQ's Options: A Look at What the Big Money is Thinkingbenzinga.com
Via Benzinga · January 13, 2025
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · January 13, 2025
Meta's Content Moderation Changes Alarm Advertisers as Zuckerberg Aligns with Trump and Muskbenzinga.com
Meta Platforms Inc (NASDAQMETA) has sparked concerns among advertisers with its restructuring of content moderation and ties to Trump and Musk. Zuckerberg's move to appease Trump and Musk has raised concerns among advertisers due to fears of harmful content and misinformation on Facebook and Instagram.
Via Benzinga · January 13, 2025
Congressman Who Wanted Airport Named After Trump Buys Bitcoin, Solana, XRP Token Ahead Of Inaugurationbenzinga.com
A member of Congress disclosed buying three cryptocurrencies in December, as the sector gets ready to welcome in a pro-cryptocurrency White House administration.
Via Benzinga · January 13, 2025
$100 Invested In Cheniere Energy 20 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · January 13, 2025
Texas Instruments Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)benzinga.com
Via Benzinga · January 13, 2025
An Interviewer Asked To See How Much Money Warren Buffett Carried In His Wallet And His Answer Is Just What You'd Expect From Himbenzinga.com
Via Benzinga · January 13, 2025
Goldman Sachs Restructures Business for Financing Growthbenzinga.com
Goldman Sachs Inc. (NYSEGS) is reorganizing its structure to focus on financing, reflecting its ambition to be a leader in the growing private credit market and private-equity dealmaking. The firm is combining three units in its global banking and markets division into a new group called the Capital Solutions Group.
Via Benzinga · January 13, 2025
Options Corner: ON Semiconductor Is Discounted But There's One Big Catchbenzinga.com
While ON Semiconductor appears to offer a legitimate value play, investors need to be aware of an unusual risk factor.
Via Benzinga · January 13, 2025
What's Going On With United States Steel Shares Monday?benzinga.com
United States Steel Corp. (NYSEX) stock is trading higher Monday following a report that Cleveland-Cliffs Inc. NYSE:CLFNYSECLF)(NYSE:NUENYSENUE to make a potential bid to acquire the company.
Via Benzinga · January 13, 2025
JD Vance Says Violent Jan. 6 Rioters 'Shouldn't Be Pardoned,' Veers From Trump's 'Major Pardons' Promisebenzinga.com
Jake Lang, who is awaiting trial on Jan. 6 charges, addressed JD Vance: 'J6 families have been CRUSHED by mixed messaging.'
Via Benzinga · January 13, 2025
Salarius Pharmaceuticals Shares Are Skyrocketing Today: What's Going On?benzinga.com
Salarius Pharmaceuticals (NASDAQSLRX) shares are trading higher Monday after the company announced a merger agreement with Decoy Therapeutics, a privately held biopharmaceutical company.
Via Benzinga · January 13, 2025
A Glimpse Into The Expert Outlook On Chemours Through 7 Analystsbenzinga.com
Via Benzinga · January 13, 2025
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · January 13, 2025
Intra-Cellular Therapies Stock Is Surging Monday: What's Going On?benzinga.com
Shares of Intra-Cellular Therapies Inc. (NASDAQITCI) are trading higher Monday after Johnson & Johnson agreed to acquire the company.
Via Benzinga · January 13, 2025
Broadcom's $3 Billion Bet: Balancing Market Signals, AI-Driven Growthbroadcom
Broadcom Inc. (AVGO) navigates bullish trend but faces selling pressure.
Via Benzinga · January 13, 2025
United Airlines Earnings Preview: Could Airline Impress Investors After Delta's Strong Guidance?benzinga.com
A United Airlines analyst sees clear skies ahead for company after Delta's recent earnings per share and revenue beat.
Via Benzinga · January 13, 2025
Decoding CrowdStrike Holdings's Options Activity: What's the Big Picture?benzinga.com
Via Benzinga · January 13, 2025
Northrop Grumman's Options Frenzy: What You Need to Knowbenzinga.com
Via Benzinga · January 13, 2025
What's Going On With Vera Therapeutics Stock?benzinga.com
Vera Therapeutics shares are trading lower by 4.7% Monday afternoon. The company announced an exclusive license agreement with Stanford University for VT-109.
Via Benzinga · January 13, 2025
How Trump's 'Maganomics' Could Power Industrials-Focused ETFsbenzinga.com
Maganomics is Trump's economic plan to boost domestic manufacturing, attracting investors and causing divided opinions. ETFs heavy in manufacturing may benefit.
Via Benzinga · January 13, 2025
ON Semi Sees Utilization Cuts As EV Demand Softens, Analyst Warnsbenzinga.com
Bolton maintains Buy rating for ON Semiconductor and lowers price target to $66. Weak demand, inventory digestion, and lowered utilization rates expected to impact revenue and margins in near term.
Via Benzinga · January 13, 2025
Stocks Edge Down Ahead Of Key Inflation Reports, Crude Hits 5-Month High, Bitcoin Sinks: What's Driving Markets Monday?benzinga.com
Traders adopted a cautious approach on Monday as they awaited two critical inflation reports due later this week, seeking clarity on Federal Reserve interest rate policy.
Via Benzinga · January 13, 2025
DatChat (DATS) Stock Jumps After Last Week's Plunge: What's Going On?benzinga.com
DatChat shares climbed 14.5% on Monday. Monday's rally occurred despite no new company-specific updates.
Via Benzinga · January 13, 2025
Spotlight on GameStop: Analyzing the Surge in Options Activitybenzinga.com
Via Benzinga · January 13, 2025
3 Energy Stocks to Buy After Biden's Offshore Oil Banbenzinga.com
Biden's drilling ban in certain US coastal areas may impact energy stocks in the future. Limited short-term effects, but could lead to higher prices.
Via Benzinga · January 13, 2025
What's Going On With CVS, Humana and UnitedHealth Shares Monday?benzinga.com
Shares of health insurance companies are trading higher after The Centers for Medicare and Medicaid Services proposed a rise to Medicare Advantage payments.
Via Benzinga · January 13, 2025
Instacart, Uber Deal 'Makes More Sense Now,' Analyst Says: Here's Whybenzinga.com
Maplebear, which owns Instacart, could be an enticing acquisition for Uber as it looks to diversify revenue streams away from mobility.
Via Benzinga · January 13, 2025
Gold Down Over 1%; Salarius Pharmaceuticals Shares Surgebenzinga.com
Via Benzinga · January 13, 2025
TikTok Ban Deadline Ahead: What Will Happen To App On Your Phone?benzinga.com
A TikTok ban could be bad for content creators and good for social media rivals. A look at what's next, including what happens to the app on your phone.
Via Benzinga · January 13, 2025
Biogen Bid For Sage Therapeutics Could Strengthen Neurology Strategy: Analystsbenzinga.com
Biogen proposes acquiring Sage Therapeutics for $7.22 per share, as analysts highlight the strategic value of Zurzuvae's success in postpartum depression.
Via Benzinga · January 13, 2025
Demystifying Magnolia Oil & Gas: Insights From 5 Analyst Reviewsbenzinga.com
Via Benzinga · January 13, 2025
Deep Dive Into Xylem Stock: Analyst Perspectives (6 Ratings)benzinga.com
Via Benzinga · January 13, 2025
Demystifying ARM Holdings: Insights From 10 Analyst Reviewsbenzinga.com
Via Benzinga · January 13, 2025
Pure Storage's Options: A Look at What the Big Money is Thinkingbenzinga.com
Via Benzinga · January 13, 2025
The Analyst Verdict: Blackstone In The Eyes Of 19 Expertsbenzinga.com
Via Benzinga · January 13, 2025
Bitcoin's Big Macro Data Week: Here's What To Watchbenzinga.com
Bitcoin (CRYPTO: BTC) faces several key macroeconomic data releases this week, causing heightened volatility in the markets.
Via Benzinga · January 13, 2025
Nordstrom Balances Strong Holiday Sales And Competition, Analysts Highlight Margin Pressurebenzinga.com
Telsey Advisory Group analyst Dana Telsey maintained a Market Perform rating for Nordstrom, setting a $24 price target. While showing strong momentum, Nordstrom faces potential gross margin pressure from competitive strategies.
Via Benzinga · January 13, 2025
Can A K-9 Drug Sniffer Land You In Jail For Cannabis? Florida Court Sets New Limitsbenzinga.com
In possible landmark ruling, a Florida appeals court has determined that a drug-sniffing dog's alert alone does justify a police search.
Via Benzinga · January 13, 2025
Stock Of The Day: Will Mondelez Rally? There's A Chance The Selloff Will Endbenzinga.com
There is also a good chance that the stock reverses and moves higher. This is why Mondelez is our Stock of the Day.
Via Benzinga · January 13, 2025
Trump Cabinet Confirmation Hearings Begin Tuesday: Pete Hegseth, Doug Collins Up Firstbenzinga.com
President-elect Donald Trump's cabinet picks are set to begin the confirmation process with several appearing before Senate committees this week. Former Fox News host Pete Segeth and former Georgia congressman Doug Collins are up first on Tuesday.
Via Benzinga · January 13, 2025
American Electric Power Is Attractive Going Forward, Analyst Double-Upgrades Stockbenzinga.com
Bank of America Securities analyst Julien Dumoulin-Smith upgraded American Electric Power to a Buy rating and raised the price target to $104, up from $98. The upgrade follows AEP's sale of a 19.9% stake in transmission assets for $2.8 billion and the appointment of Trevor Mihalik as CFO.
Via Benzinga · January 13, 2025
What's Going On With 22nd Century Group Shares Monday?benzinga.com
22nd Century stock is moving higher on Monday after the company announced its readiness to support the FDA's proposed standard to mandate reduced nicotine content in cigarettes.
Via Benzinga · January 13, 2025
Tether To Relocate Headquarters To El Salvadorbenzinga.com
Tether (CRYPTO: USDT) on Monday announced it has acquired a Digital Asset Service Provider (DASP) license by El Salvador, allowing it to subsequently relocate its operations to
Via Benzinga · January 13, 2025
Netflix Stock Has 'Long Term Runway For Dominance In Streaming': Analyst Highlights 4 Key Catalystsbenzinga.com
A Netflix analyst says the company could beat subscriber growth estimates and highlights its growing advertising monetization in the fourth quarter.
Via Benzinga · January 13, 2025
Exact Sciences Sparks Analyst Optimism Amid Competitive Multi-Cancer Test Marketbenzinga.com
Exact Sciences' 2024 sales grew 10% to $2.76 billion, exceeding estimates. New cancer tests, including Cologuard Plus, are set for 2025 launch.
Via Benzinga · January 13, 2025
13 Analysts Have This To Say About Intellia Therapeuticsbenzinga.com
Via Benzinga · January 13, 2025